- Home
- PAR vs CPRX Comparison
PAR vs CPRX Comparison
Compare PAR & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAR
- CPRX
- Stock Information
- Founded
- PAR 1968
- CPRX 2002
- Country
- PAR United States
- CPRX United States
- Employees
- PAR N/A
- CPRX N/A
- Industry
- PAR Office Equipment/Supplies/Services
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- PAR Miscellaneous
- CPRX Health Care
- Exchange
- PAR Nasdaq
- CPRX Nasdaq
- Market Cap
- PAR 2.6B
- CPRX 2.8B
- IPO Year
- PAR N/A
- CPRX 2006
- Fundamental
- Price
- PAR $62.21
- CPRX $21.62
- Analyst Decision
- PAR Strong Buy
- CPRX Strong Buy
- Analyst Count
- PAR 8
- CPRX 8
- Target Price
- PAR $79.25
- CPRX $32.25
- AVG Volume (30 Days)
- PAR 351.1K
- CPRX 902.0K
- Earning Date
- PAR 02-28-2025
- CPRX 02-26-2025
- Dividend Yield
- PAR N/A
- CPRX N/A
- EPS Growth
- PAR N/A
- CPRX 114.68
- EPS
- PAR N/A
- CPRX 1.18
- Revenue
- PAR $453,986,000.00
- CPRX $460,482,000.00
- Revenue This Year
- PAR N/A
- CPRX $24.00
- Revenue Next Year
- PAR $20.43
- CPRX $15.13
- P/E Ratio
- PAR N/A
- CPRX $18.34
- Revenue Growth
- PAR 49.11
- CPRX 32.17
- 52 Week Low
- PAR $37.74
- CPRX $13.70
- 52 Week High
- PAR $82.24
- CPRX $24.64
- Technical
- Relative Strength Index (RSI)
- PAR 25.33
- CPRX 40.14
- Support Level
- PAR $66.91
- CPRX $22.18
- Resistance Level
- PAR $68.84
- CPRX $23.59
- Average True Range (ATR)
- PAR 2.00
- CPRX 0.70
- MACD
- PAR -0.74
- CPRX -0.17
- Stochastic Oscillator
- PAR 3.62
- CPRX 11.30
About PAR PAR Technology Corporation
PAR Technology Corp together with its subsidiaries provides management technology solutions including software, hardware, and related services, integral to the point-of-sale infrastructure and task management, information gathering, assimilation, and communication services. It has two segments. The restaurant/ Retail segment provides point-of-sale and management technology solutions such as hardware, software, and integrated technical solutions to the restaurant and retail industries. The government segment provides intelligence, surveillance, and reconnaissance solutions and mission systems support. The company derives the majority of its revenues from the Restaurant/ Retail segment.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.